Viewing Study NCT04158635


Ignite Creation Date: 2025-12-24 @ 10:33 PM
Ignite Modification Date: 2025-12-25 @ 8:05 PM
Study NCT ID: NCT04158635
Status: RECRUITING
Last Update Posted: 2025-08-19
First Post: 2019-11-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage III Pancreatic Cancer AJCC v8 View
None Stage IV Pancreatic Cancer AJCC v8 View
None Unresectable Pancreatic Carcinoma View
Keywords: